Glyscend Company

Venture-backed, clinical-stage biopharmaceutical companyGlyscend Therapeutics is a venture-backed, clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and Us - /?

Investors

Headquarters: United States
Employee Number: 22
Technology: Biotechnology
Industry: Biotechnology
Founded Date: 2014.0
Register and Claim Ownership